SciBase Holding Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Pia Renaudin

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	less than a year
CEO ownership	n/a
Management average tenure	9.3yrs
Board average tenure	9.1yrs

Recent management updates

Recent updates

CEO

Pia Renaudin (56 yo)

less than a year

Tenure

Ms. Pia Renaudin serves as Chief Executive Officer at SciBase Holding AB (publ) since October 01, 2023 SciBaseHe served as Chief Executive Officer at Senzime AB (publ) since February 08, 2019 until May 03,...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Pia Renaudin	Chief Executive Officer	less than a year	no data	no data
Stig Ollmar	Founder & Chief Scientific Officer	26.3yrs	no data	no data
Michael Colérus	Chief Financial Officer	10.3yrs	kr272.54k	0.060% SEK 2.0k
Per Svedenhag	Head of Business Development & Marketing	9.3yrs	kr1.43m	0.047% SEK 1.6k
Tobias Bergenblad	Global Sales Director	9.3yrs	no data	0.060% SEK 2.0k

9.3yrs

Average Tenure

61yo

Average Age

Experienced Management: 5J3's management team is seasoned and experienced (9.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Thomas Taapken	Independent Director	7yrs	kr150.00k	0.024% SEK 802.3
Tord Lendau	Chairman	10.3yrs	kr200.00k	1.13% SEK 36.9k
Matt Leavitt	Independent Director	3yrs	kr150.00k	1.55% SEK 50.7k
Per Nordberg	Deputy Director	7.3yrs	no data	no data
Allan Halpern	Member of Scientific Advisory Board	9.1yrs	no data	no data
Scott Menzies	Member of Scientific Advisory Board	9.1yrs	no data	no data
Diana Ferro	Independent Director	7yrs	kr150.00k	0.055% SEK 1.8k
David Elder	Member of Scientific Advisory Board	9.1yrs	no data	no data
Josep Malvehy	Member of Scientific Advisory Board	9.1yrs	no data	no data
Holger Hänßle	Member of Scientific Advisory Board	9.1yrs	no data	no data
Jvalini Dwarkasing	Independent Director	2.7yrs	kr113.00k	no data

9.1yrs

Average Tenure

63yo

Average Age

Experienced Board: 5J3's board of directors are considered experienced (9.1 years average tenure).

SciBase Holding Management

Management criteria checks 2/4

Key information

Recent management updates

SciBase Holding AB (publ), Annual General Meeting, May 17, 2024

SciBase Holding AB (publ) Appoints Nomination Committee

Scibase Appoints Pia Renaudin as Chief Executive Officer

SciBase Holding AB (publ) Announces Executive Changes

SciBase Holding AB (publ), Annual General Meeting, May 18, 2023

David Melin Resigns as Head of Product Development of SciBase AB

Recent updates

New major risk - Financial position

Full year 2023 earnings released: kr0.52 loss per share (vs kr0.63 loss in FY 2022)

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: kr0.11 loss per share (vs kr0.13 loss in 3Q 2022)

SciBase Holding AB (publ) to Report Fiscal Year 2023 Results on Feb 21, 2024

SciBase Holding AB (publ) to Report Q1, 2024 Results on May 09, 2024

SciBase Holding AB (publ), Annual General Meeting, May 17, 2024

SciBase Holding AB (publ) Appoints Nomination Committee

New major risk - Market cap size

SciBase Holding AB Announces the Publication of A Collaborative Scientific Project with the Swiss Institute of Allergy and Asthma Research in Davos, Switzerland

Scibase Appoints Pia Renaudin as Chief Executive Officer

Second quarter 2023 earnings released: kr0.095 loss per share (vs kr0.14 loss in 2Q 2022)

SciBase Holding AB (publ) Announces Executive Changes

Full year 2022 earnings released: kr0.63 loss per share (vs kr0.67 loss in FY 2021)

Full year 2022 earnings released: kr0.63 loss per share (vs kr0.67 loss in FY 2021)

SciBase Holding AB (publ) to Report Nine Months, 2023 Results on Nov 10, 2023

SciBase Holding AB (publ) to Report Fiscal Year 2022 Results on Feb 23, 2023

SciBase Holding AB (publ) Announces New Study Shows Nevisense Significantly Improves US Clinician's Decision-Making Beyond Dermoscopy

SciBase Holding AB (publ), Annual General Meeting, May 18, 2023

SciBase Holding AB Announces Nevisense Detects Skin Barrier Damage in Mice Caused by Household Detergents

Second quarter 2022 earnings released: kr135 loss per share (vs kr0.19 loss in 2Q 2021)

SciBase Holding AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

SciBase Holding AB (publ) Announces US Study Shows That EIS and Nevisense Significantly Improves Clinicians' Diagnostic Accuracy

SciBase Holding AB (publ) Study Shows Clinical Benefit of Nevisense

Full year 2021 earnings released: kr0.67 loss per share (vs kr1.12 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: kr0.13 loss per share (vs kr0.20 loss in 3Q 2020)

Second quarter 2021 earnings released: kr0.19 loss per share (vs kr0.38 loss in 2Q 2020)

SciBase Holding AB (publ) announced that it has received SEK 71.214109 million in funding from Van Herk Investments B.V., Ostvast Capital Management Limited, and other investors

First quarter 2021 earnings released: kr0.15 loss per share (vs kr0.54 loss in 1Q 2020)

Scibase Receives Important European MDR Certification

SciBase Holding AB (publ) Submits First Reimbursement Application to CMS in Florida

David Melin Resigns as Head of Product Development of SciBase AB

Full year 2020 earnings released: kr1.12 loss per share (vs kr2.38 loss in FY 2019)

Revenue beats expectations

SciBase Holding AB (publ) to Report Q3, 2021 Results on Nov 11, 2021

SciBase Holding AB (publ) Announces New Study Published Validating Further Nevisense Indication, Non-Melanoma Skin Cancer

New 90-day high: €0.41

Third quarter 2020 earnings released: kr0.20 loss per share

SciBase Holding AB (publ) to Report Fiscal Year 2020 Results on Feb 19, 2021

Scibase Holding AB (Publ) Announces Positive Step for US Reimbursement of Nevisense

SciBase Holding Releases Next Generation Platform, Nevisense Go

Earnings released

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age